TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address
unmet needs in soft tissue reconstruction. It offers reinforced tissue matrix products for a variety of reconstruction procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. The company provides a portfolio of OviTex Reinforced Tissue Matrix or OviTex products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix or OviTex PRS products to address the unmet needs in plastic and reconstructive surgery. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania. The company trades on NASDAQ exchange. The company headquarter is located in Malvern, PA. The company was established in the 2012.
| Ticker | TELA |
| Long Name | Tela Bio, Inc. |
| Short Name | Tela Bio |